NASDAQ · AHCO
Healthcare · Medical - Devices
$5.93
Down-$0.10 (-1.66%)
Updated Oct 30, 2026, 12:31 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · AHCO
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
AHCO closed at $5.93 after 21 trading sessions, up 4.40% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $6.12 | $6.17 | $5.905 | $5.93 | 2.08M |
| Oct 28, 2026 | $5.82 | $6.075 | $5.82 | $6.03 | 1.56M |
| Oct 27, 2026 | $5.94 | $6.05 | $5.685 | $5.85 | 2.67M |
| Oct 26, 2026 | $6.02 | $6.07 | $5.845 | $5.93 | 1.75M |
| Oct 23, 2026 | $6.13 | $6.15 | $5.96 | $6.02 | 1.64M |
| Oct 22, 2026 | $6.12 | $6.225 | $6.00 | $6.17 | 2.18M |
| Oct 21, 2026 | $6.11 | $6.20 | $6.0249 | $6.10 | 1.35M |
| Oct 20, 2026 | $5.94 | $6.115 | $5.88 | $6.10 | 2.24M |
| Oct 19, 2026 | $6.00 | $6.07 | $5.70 | $5.88 | 3.43M |
| Oct 16, 2026 | $6.43 | $6.45 | $6.00 | $6.02 | 2.09M |
| Oct 15, 2026 | $6.25 | $6.41 | $6.1656 | $6.39 | 1.61M |
| Oct 14, 2026 | $6.32 | $6.38 | $6.20 | $6.25 | 1.82M |
| Oct 13, 2026 | $6.20 | $6.42 | $6.18 | $6.33 | 2.16M |
| Oct 12, 2026 | $6.07 | $6.18 | $6.03 | $6.14 | 1.53M |
| Oct 9, 2026 | $6.10 | $6.105 | $5.965 | $6.06 | 1.46M |
| Oct 8, 2026 | $5.85 | $6.11 | $5.82 | $6.065 | 3.04M |
| Oct 7, 2026 | $5.77 | $6.055 | $5.68 | $5.88 | 2.88M |
| Oct 6, 2026 | $5.76 | $5.89 | $5.72 | $5.77 | 2.53M |
| Oct 5, 2026 | $5.52 | $5.83 | $5.51 | $5.74 | 3.26M |
| Oct 2, 2026 | $5.73 | $5.80 | $5.60 | $5.60 | 1.73M |
| Oct 1, 2026 | $5.65 | $5.73 | $5.50 | $5.68 | 2.03M |
The latest Smart Investors Daily articles mentioning AHCO.
Company
Market Activity
Research & News
AHCO research
Company profile and research snapshot.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 17, 2026 | Baird | Outperform | — |
| Aug 6, 2026 | RBC Capital | Outperform | — |
| Aug 6, 2026 | UBS | Buy | — |
| Aug 5, 2026 | Truist Securities | Buy | — |
| Jul 21, 2026 | Jefferies | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 21, 2026
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.
Yahoo · Oct 21, 2026
CONSHOHOCKEN, Pa., October 21, 2026--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2026 financial results before the opening of the financial markets on Tuesday, November 3, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts a
Yahoo · Oct 14, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Yahoo · Sep 22, 2026
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AHCO.
